全文获取类型
收费全文 | 107457篇 |
免费 | 9678篇 |
国内免费 | 3660篇 |
专业分类
耳鼻咽喉 | 353篇 |
儿科学 | 1581篇 |
妇产科学 | 1310篇 |
基础医学 | 7206篇 |
口腔科学 | 1609篇 |
临床医学 | 10505篇 |
内科学 | 17304篇 |
皮肤病学 | 1418篇 |
神经病学 | 2875篇 |
特种医学 | 1188篇 |
外国民族医学 | 15篇 |
外科学 | 3956篇 |
综合类 | 14585篇 |
现状与发展 | 11篇 |
一般理论 | 3篇 |
预防医学 | 9185篇 |
眼科学 | 936篇 |
药学 | 35173篇 |
41篇 | |
中国医学 | 4478篇 |
肿瘤学 | 7063篇 |
出版年
2024年 | 274篇 |
2023年 | 1551篇 |
2022年 | 2862篇 |
2021年 | 4144篇 |
2020年 | 3698篇 |
2019年 | 3654篇 |
2018年 | 3743篇 |
2017年 | 3897篇 |
2016年 | 4017篇 |
2015年 | 4201篇 |
2014年 | 7047篇 |
2013年 | 10421篇 |
2012年 | 7248篇 |
2011年 | 7593篇 |
2010年 | 6006篇 |
2009年 | 5419篇 |
2008年 | 5377篇 |
2007年 | 5414篇 |
2006年 | 4803篇 |
2005年 | 4265篇 |
2004年 | 3547篇 |
2003年 | 3028篇 |
2002年 | 2387篇 |
2001年 | 2204篇 |
2000年 | 1749篇 |
1999年 | 1519篇 |
1998年 | 1291篇 |
1997年 | 1214篇 |
1996年 | 1001篇 |
1995年 | 867篇 |
1994年 | 763篇 |
1993年 | 642篇 |
1992年 | 703篇 |
1991年 | 584篇 |
1990年 | 455篇 |
1989年 | 395篇 |
1988年 | 355篇 |
1987年 | 353篇 |
1986年 | 262篇 |
1985年 | 321篇 |
1984年 | 249篇 |
1983年 | 185篇 |
1982年 | 204篇 |
1981年 | 154篇 |
1980年 | 120篇 |
1979年 | 110篇 |
1978年 | 104篇 |
1977年 | 87篇 |
1976年 | 88篇 |
1975年 | 77篇 |
排序方式: 共有10000条查询结果,搜索用时 31 毫秒
151.
[背景]观察抗结核药物的不良反应.[病例报告]对293例应用抗结核药物后出现不良反应的患者资料进行分析,抗结核药物常见不良反应的有肝脏损害、胃肠道反应、听力障碍及关节痛等.[讨论]应依据患者的具体情况,选择不同的抗结核药物进行联合应用. 相似文献
152.
通过8名健康志愿者服药后的对照实验,用微生物法检测血药浓度,按一室模型配置求算药物动力学参数,探讨西咪替丁对林可霉素体内过程的影响。结果表明,西咪替丁不能改变林可霉素的吸收速率(Ka)和消除速率(Ke),但可通过增加其吸收程度或改变其分布容积,使林可霉素的血药浓度和生物利用度分别增加约19%和27%。 相似文献
153.
目的 评价耐药对地区肺结核病治疗效果的影响.方法 对上海地区2004年2月-9月新登记敏感及耐药肺结核病人1年治疗转归进行分析和比较.结果 在全市各区(县)结核病定点医院新登记1 597例肺结核病病人中,805例培养阳性,其中731例经菌型鉴定为结核分枝杆菌的病人纳入分析.731例病人的总耐药率为18.7%,耐多药率为6.7%.敏感组治疗成功率达到93.0%,非MDR的耐药病人治疗成功率达到85%以上,MDR组治疗成功率为71.4%.经x2检验,差别有统计学意义(x2=83.996 8,P<0.01).在68例治疗不成功的病人中,耐药病人占38.2%;而在30例治疗失败的病人中,耐药病人占60%.复治敏感病人的治疗成功率(92.0%)与初治敏感病人(93.1%)相当,但是复治耐药病人的治疗成功率远低于初治耐药病人.结论 (1)上海地区肺结核病病人治疗管理效果良好;(2)耐药是肺结核病治疗失败的重要因素,应加强和改进对耐药结核病的治疗措施;(3)耐药和敏感病人治疗效果存在较大差异,应分别评价. 相似文献
154.
目的:评价乳胶结合实验,检测重症监护病房(ICU)耐甲氧西林金黄色葡萄球菌(MRSA)及其肠毒素(SE),并进行耐药性分析。方法:收集260株金黄色葡萄球菌临床分离株,通过药敏试验将其分为耐甲氧西林金黄色葡萄球菌和甲氧西林敏感金黄色葡萄球菌(MSSA),用反向间接血凝试验(RPHA)检测金黄色葡萄球菌肠毒素。结果:MRSA产肠毒素为134株,MSSA产肠毒素为38株,MRSA产肠毒素率为100%,MSSA产肠毒素率为30%。结论:重症监护病房应重视MRSA的检测和金黄色葡萄球菌肠毒素的检测,合理使用广谱抗菌药物。 相似文献
155.
A rapid nonsterile short-term assay has been investigated in which percent inhibition of incorporation of the DNA precursor (3H)-thymidine is measured following exposure of tumor cells to the test drugs. To evaluate the usefulness of the short-term assay in providing a rapid reliable assessment of chemotherapeutic response, the short-term assay was compared with the soft agar clonogenic assay. Sensitivity to five anticancer drugs was compared using three human tumor cell lines (epidermoid carcinoma of the oral cavity, pancreatic carcinoma, and bladder carcinoma). The short-term assay produced results that were similar to results of the clonogenic assay in two of the three tumors tested, for three drugs (cis-platin, doxorubicin, and BCNU), but did not detect responses to two antimetabolites (5-FU and MTX) in any tumor. Further studies of this short-term assay should focus on alkylating agents and other nonantimetabolites. 相似文献
156.
157.
Nutritional-inflammation status and resistance to erythropoietin therapy in haemodialysis patients. 总被引:1,自引:0,他引:1
Francesco Locatelli Simeone Andrulli Bruno Memoli Camilla Maffei Lucia Del Vecchio Stefano Aterini Walter De Simone Antonella Mandalari Giuliano Brunori Marcello Amato Bruno Cianciaruso Carmine Zoccali 《Nephrology, dialysis, transplantation》2006,21(4):991-998
BACKGROUND: Chronic kidney disease patients who are resistant to erythropoietin (EPO) treatment may suffer from malnutrition and/or inflammation. METHODS: In a cross-sectional study of haemodialysis patients, we investigated the relationship between the natural logarithm of the weekly EPO dose normalized for post-dialysis body weight and outcome measures of nutrition and/or inflammation [BMI, albumin and C reactive protein (CRP)] by means of multiple linear regression analysis. On the basis of the decile distribution of weekly EPO doses, we also evaluated four groups of patients: untreated, hyper-responders, normo-responders and hypo-responders. RESULTS: Six hundred and seventy-seven adult haemodialysis patients were recruited from five Italian centres. BMI and albumin were lower in the hypo-responders than in the other groups (21.3+/-3.8 vs 24.4+/-4.7 kg/m(2), P<0.001; and 3.8+/-0.6 vs 4.1+/-0.4 g/dl, P<0.001), whereas the median CRP level was higher (1.9 vs 0.8 mg/dl, P = 0.004). The median weekly EPO dose ranged from 30 IU/kg/week in the hyper-responsive group to 263 IU/kg/week in the hypo-responsive group. Transferrin saturation linearly decreased from the hyper- to hypo-responsive group (37+/-15 to 25+/-10%, P = 0.003), without any differences in transferrin levels. Ferritin levels were lower in the hypo-responsive than in the other patients (median 318 vs 445 ng/ml, P = 0.01). At multiple linear regression analysis, haemoglobin, BMI, albumin, CRP and serum iron levels were independently associated with the natural logarithm of the weekly EPO dose (R(2) = 0.22). CONCLUSIONS: Our findings support a clear association between EPO responsiveness and nutritional and inflammation variables in haemodialysis patients; iron deficiency is still a major cause of hypo-responsiveness. 相似文献
158.
P. Boissonnat M. de Lorgeril V. Perroux P. Salen A. M. Batt J. C. Barthelemy R. Brouard E. Serres J. Delaye 《European journal of clinical pharmacology》1997,53(1):39-45
Objectives: Previous uncontrolled studies have suggested an interaction between ticlopidine, a major antiplatelet agent, and cyclosporin
in heart- and kidney-transplant recipients. The aims of this study were to examine in a randomised, double-blind fashion,
the possible interaction between cyclosporin A and ticlopidine (250 mg per day) and the tolerability of this combination in
heart-transplant recipients.
Methods: Twenty heart-transplant recipients were randomised into either a treated or a placebo group. Blood samples were drawn for
time-course evaluation of cyclosporin blood levels over a period of 12 h, following the morning intake of cyclosporin and,
for platelet aggregation studies, before and after 14 days of ticlopidine administration. Twenty four-hour urine samples were
collected for 6-β-hydroxycortisol measurements, before and after 14 days of ticlopidine.
Results: Although given at half the recommended daily dosage, ticlopidine significantly reduced platelet aggregation. Pharmacokinetic
parameters indicate that the bioavailability of cyclosporin A was not significantly modified by ticlopidine. However, one
patient in the ticlopidine group was withdrawn because of a major fall in cyclosporin blood level within 3 days of treatment.
Urinary excretion of 6-β-hydroxycortisol was augmented after treatment in the ticlopidine group compared with the placebo
group, suggesting that induction of drug metabolism might have occurred. Data also show quite a large intra-individual variability
in cyclosporin bioavailability in the placebo group, suggesting that poor absorption of the drug formulation and/or poor compliance
might have contributed to the decreased cyclosporin blood levels in the patient withdrawn from this study and in previous
uncontrolled studies.
Conclusion: Cyclosporin bioavailability was not clearly modified by a half dosage of ticlopidine in this study. We, however, recommend
closely monitoring cyclosporin blood levels when prescribing ticlopidine. Further studies will be needed with new formulations
of cyclosporin or when using the full dosage of ticlopidine.
Received: 20 July 1996 / Accepted in revised form: 12 February 1997 相似文献
159.
特异性荧光偏振免疫法监测521例肾移植后环孢素A全血浓度3275次 总被引:2,自引:0,他引:2
目的通过监测肾移植后病人环孢素A(CsA)全血浓度 ,提出CsA在三联免疫抑制用药方案中的理想治疗窗。方法用特异性荧光偏振免疫法测定CsA全血浓度 ,对521例病人监测3275次 ,按术后时间及临床表现分组比较。结果肾移植后<1 ,、1~3、3~6、6~12个月、1~2和>2年的CsA全血谷浓度的理想治疗窗应分别为250~450、200~400、150~300、100~250、100~200和100~180μg/L。结论CsA全血浓度在上述范围内 ,中毒反应和排异反应明显减少 相似文献
160.
本文采用个人自填问卷方式,对青岛市某高校三年级和五年级学生使用包括酒类、香烟在内的精神药物的情况进行调查。结果表明大学生对酒、香烟等精神药物的使用较为普遍。其中烟、酒的使用率随着年级的增长而提高,五年级学生饮酒、抽烟率明显高于三年级学生(P<0.05)。提示大学生中酒、香烟等精神药物的使用问题是值得注意的。 相似文献